Templin, Christian; Volkmann, Julia; Emmert, Maximilian Y; Mocharla, Pavani; Müller, Maja; Kraenkel, Nicolle; Ghadri, Jelena R; Meyer, Martin; Styp-Rekowska, Beata; Briand, Sylvie; Klingenberg, Roland; Jaguszewski, Milosz; Matter, Christian M; Djonov, Valentin; Mach, Francois; Windecker, Stephan; Hoerstrup, Simon P; Thum, Thomas; Lüscher, Thomas F and Landmesser, Ulf (2017). Increased Proangiogenic Activity of Mobilized CD34+ Progenitor Cells of Patients With Acute ST-Segment-Elevation Myocardial Infarction: Role of Differential Micro-RNA-378 Expression. Arteriosclerosis, thrombosis, and vascular biology, 37(2), pp. 341-349. Lippincott Williams & Wilkins 10.1161/ATVBAHA.116.308695
Text
341.full.pdf - Published Version Restricted to registered users only Available under License Publisher holds Copyright. Download (3MB) |
OBJECTIVE
Proangiogenic effects of mobilized bone marrow-derived stem/progenitor cells are essential for cardiac repair after myocardial infarction. Micro-RNAs (miRNA/miR) are key regulators of angiogenesis. We investigated the differential regulation of angio-miRs, that is, miRNAs regulating neovascularization, in mobilized CD34(+) progenitor cells obtained from patients with an acute ST-segment-elevation myocardial infarction (STEMI) as compared with those with stable coronary artery disease or healthy subjects.
APPROACH AND RESULTS
CD34(+) progenitor cells were isolated from patients with STEMI (on day 0 and day 5), stable coronary artery disease, and healthy subjects (n=27). CD34(+) progenitor cells of patients with STEMI exhibited increased proangiogenic activity as compared with CD34(+) cells from the other groups. Using a polymerase chain reaction-based miRNA-array and real-time polymerase chain reaction validation, we identified a profound upregulation of 2 known angio-miRs, that is, miR-378 and let-7b, in CD34(+) cells of patients with STEMI. Especially, we demonstrate that miR-378 is a critical regulator of the proangiogenic capacity of CD34(+) progenitor cells and its stimulatory effects on endothelial cells in vitro and in vivo, whereas let-7b upregulation in CD34(+) cells failed to proof its effect on endothelial cells in vivo.
CONCLUSIONS
The present study demonstrates a significant upregulation of the angio-miRs miR-378 and let-7b in mobilized CD34(+) progenitor cells of patients with STEMI. The increased proangiogenic activity of these cells in patients with STEMI and the observation that in particular miR-378 regulates the angiogenic capacity of CD34(+) progenitor cells in vivo suggest that this unique miRNA expression pattern represents a novel endogenous repair mechanism activated in acute myocardial infarction.
Item Type: |
Journal Article (Original Article) |
---|---|
Division/Institute: |
04 Faculty of Medicine > Department of Cardiovascular Disorders (DHGE) > Clinic of Cardiology |
UniBE Contributor: |
Windecker, Stephan |
Subjects: |
600 Technology > 610 Medicine & health |
ISSN: |
1079-5642 |
Publisher: |
Lippincott Williams & Wilkins |
Language: |
English |
Submitter: |
Judith Liniger |
Date Deposited: |
05 Apr 2017 10:27 |
Last Modified: |
05 Dec 2022 15:01 |
Publisher DOI: |
10.1161/ATVBAHA.116.308695 |
PubMed ID: |
28062497 |
Uncontrolled Keywords: |
coronary artery disease; endothelial cells; microRNAs; myocardial infarction; real-time polymerase chain reaction |
BORIS DOI: |
10.7892/boris.93521 |
URI: |
https://boris.unibe.ch/id/eprint/93521 |